• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

Professional Introduction to 3-Bromo-4-iodophenol (CAS No. 1037298-05-7)

3-Bromo-4-iodophenol is a significant compound in the field of organic synthesis and pharmaceutical research, characterized by its unique bromo and iodo substituents on a phenolic ring. This compound, identified by the Chemical Abstracts Service Number (CAS No.) 1037298-05-7, has garnered considerable attention due to its versatile applications in medicinal chemistry and material science. The presence of both bromine and iodine atoms on the aromatic ring enhances its reactivity, making it a valuable intermediate in the synthesis of various bioactive molecules.

The structural features of 3-Bromo-4-iodophenol contribute to its utility in cross-coupling reactions, which are fundamental in constructing complex molecular architectures. These reactions include Suzuki-Miyaura, Stille, and Sonogashira couplings, where the halogen atoms serve as pivotal handles for palladium-catalyzed transformations. Recent advancements in synthetic methodologies have highlighted the compound's role in generating novel heterocyclic frameworks, which are often explored for their pharmacological properties.

In the realm of pharmaceutical development, 3-Bromo-4-iodophenol has been utilized as a precursor in the synthesis of kinase inhibitors and antimicrobial agents. The bromo and iodo groups facilitate the introduction of diverse functional moieties, enabling the creation of libraries of compounds for high-throughput screening. For instance, studies have demonstrated its application in developing small-molecule inhibitors targeting protein-protein interactions critical in cancer therapy. The ability to modify the phenolic core while retaining potent biological activity makes this compound indispensable in drug discovery pipelines.

Moreover, the compound's significance extends to materials science, particularly in the design of organic electronic materials. The halogenated aromatic system exhibits tunable electronic properties, making it suitable for applications in organic light-emitting diodes (OLEDs) and photovoltaic devices. Researchers have leveraged the reactivity of 3-Bromo-4-iodophenol to develop novel copolymers with enhanced charge transport capabilities. These advancements underscore the compound's multifaceted role in bridging organic synthesis with cutting-edge technological applications.

The latest research trends indicate that 3-Bromo-4-iodophenol is being increasingly explored for its potential in medicinal chemistry beyond traditional applications. For example, studies have investigated its role as a building block for antiviral and anti-inflammatory agents. The structural motif allows for selective modifications that can mimic natural products or bioactive peptides, providing a scaffold for structure-based drug design. Such investigations highlight the compound's adaptability and its contribution to expanding therapeutic strategies.

The synthetic accessibility of 3-Bromo-4-iodophenol is another factor that underscores its importance. Efficient synthetic routes have been developed, enabling large-scale production for industrial and research purposes. These methods often involve halogen exchange reactions or direct functionalization of simpler precursors, ensuring a reliable supply chain for downstream applications. The ease of obtaining high-purity material further enhances its utility in sensitive experimental protocols.

In conclusion, 3-Bromo-4-iodophenol (CAS No. 1037298-05-7) represents a cornerstone compound in modern chemical research. Its unique structural features and reactivity make it indispensable in pharmaceutical synthesis, material science, and advanced organic transformations. As research continues to uncover new applications and methodologies, this compound is poised to remain at the forefront of innovation across multiple scientific disciplines.

• 124311-19-9(Phenol, 3-bromo-2,4,6-triiodo-)
• 570391-20-7(3-Bromo-5-iodophenol)
• 4897-68-1(1-bromo-2-iodo-4-methoxy-benzene)
• 858855-11-5(5-Bromo-2-iodophenol)
• 202865-84-7(4-bromo-3-iodoPhenol)
• 466639-53-2(2-Bromo-1-iodo-4-methoxybenzene)
• 201161-11-7(1,3-Dibromo-2-iodo-5-methoxybenzene)
• 556038-75-6(3,5-dibromo-4-iodophenol)
• 855836-52-1(3-Bromo-2-iodophenol)
• 863870-88-6(2-Bromo-3-iodophenol)